CLBTCellebrite DI Ltd

Upcoming Earnings

We were not able to find an announced earnings date for this symbol yet. Check back again later

Company Info

CEO

Yossi Carmil

Location

N/A, Israel

Exchange

Nasdaq

Website

https://cellebrite.com

Summary

Cellebrite DI Ltd.

Company Info

CEO

Yossi Carmil

Location

N/A, Israel

Exchange

Nasdaq

Website

https://cellebrite.com

Summary

Cellebrite DI Ltd.

AI Insights for CLBT
2 min read

Quick Summary

Cellebrite DI Ltd. is a leading provider of digital intelligence solutions primarily targeted at law enforcement agencies, government entities, and global enterprises. The company’s core platform enables users to collect, review, analyze, and manage digital data across the entire investigative lifecycle. Its software assists in a range of legal investigations, including cybercrimes, child exploitation, homicide, anti-terrorism operations, border control, and human trafficking. Cellebrite’s clientele is diverse, encompassing law enforcement, border authorities, intelligence services, and private sector forensic teams worldwide. The company positions itself as a vital player in digital forensics and data intelligence, supporting over 7,000 customers globally.

The Bull Case

  • Cellebrite benefits from a leading market position in digital intelligence for investigations, with a strong global brand recognized by law enforcement and enterprise customers.
  • Its focus on high-margin SaaS and subscription solutions drives recurring revenue and enhances profitability.
  • The company has demonstrated robust customer retention and the ability to cross-sell additional products and enhancements.
  • Recent innovations, including AI-powered investigative tools and the integration of Corellium technology, underscore a commitment to staying ahead in technological advancements.
  • Strategic leadership appointments and a growing customer base further reinforce its competitive edge.

The Bear Case

  • Despite recent profitability, Cellebrite has historically reported negative earnings and still trades at a premium price-to-book value.
  • Its reliance on large contracts, particularly with U.S.
  • federal agencies, introduces risk if those relationships falter or are delayed.
  • The company’s elevated valuation compared to industry peers may deter some investors, especially if future growth slows.
  • Integration risks from acquisitions and operational challenges in scaling new SaaS offerings also present vulnerabilities.

Key Risks

  • Cellebrite faces external risks from budgetary pressures or policy changes affecting government procurement, especially in the U.S., its key market.
  • Increasing competition from established and emerging digital forensics vendors could erode market share or pressure pricing.
  • Rapid technological change demands ongoing R&D investment to maintain leadership.
  • The company’s high valuation makes it sensitive to growth shortfalls or market downturns, potentially resulting in sharp share price corrections.

What to Watch

UpcomingIn the most recent quarter, Cellebrite reported robust revenue growth, achieving $126 million in revenue (up 18% year-over-year) and a swing to profitability with a $20.2 million net income compared to a significant loss the prior year.
UpcomingThe company completed or neared completion of the Corellium acquisition, bolstering its mobile analysis capabilities.
UpcomingThere was a substantial increase in subscription sales (21% YoY) and a strong rise in ARR to $440 million.
ExpectedLooking into the next quarter, Cellebrite is expected to maintain strong momentum in both revenue and ARR growth, projected at $470–$475 million and $460–$475 million respectively for FY2025.

Price Drivers

  • Cellebrite's stock price is heavily influenced by its reported earnings results, especially metrics such as revenue growth, Adjusted EBITDA, and guidance on annual recurring revenue (ARR).
  • The company’s rapid transition to SaaS and subscription-based sales has driven increasing recurring revenues and strong gross margins, drawing positive investor sentiment.
  • Additionally, strategic product launches, acquisitions like Corellium, and key wins in the U.S.
  • federal sector act as catalysts.

Recent News

  • Recent news highlights include the appointment of new CFO David Barter and CMO David Gee, signaling a focus on financial discipline and global marketing expansion.
  • The company reported strong Q3 results, swinging to profitability and raising full-year guidance for both revenue and profitability.
  • The Autumn 2025 Release featured major product enhancements, including AI-driven analysis and expanded device support.
  • Cellebrite neared the completion of the Corellium acquisition, further strengthening its platform capabilities.

Market Trends

  • Broader market trends point to increased reliance on digital intelligence and forensics solutions as law enforcement and private entities confront rising volumes of digital evidence.
  • The move towards SaaS and subscription models reflects a demand for scalable, predictable services and has driven valuation premiums for leading software vendors.
  • Advances in AI are transforming how investigations are conducted, with automation and machine learning becoming central differentiators.
  • However, these trends also bring heightened competition, greater scrutiny on data privacy, and more stringent regulatory environments, all influencing operational strategies and shareholder expectations across the sector.

Community Research

Research from investors like you

Be the first to share your analysis on CLBT

Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.

Topics: Company overview • Products • Competitors • Strengths & Risks

Symbol's posts

avatar
@Kokorache 2 months ago

Motley Fool suggests rotating into these 10 small-cap AI stocks

Motley Fool suggests rotating into these 10 small-cap AI stocks

post thumbnail

No more topics to show